Loading...

About Diag2Tec’s Team and Scientific Board

About Diag2Tec’s Team and Scientific Board 2018-03-01T14:54:07+00:00

Meet Our Executive Team

Angélique BRUYER
Angélique BRUYERLaboratory Director and Co-Founder President
Co-founder of Diag2Tec, Angélique has a Master in Molecular Biology. She has been Research Engineer into the group « Diagnosis and minimal residual disease of MM patients » CHU Montpellier, She has been in charge of in vitro culture of MM Cell lines and in charge of predictive signatures development.
Jérôme MOREAUX
Jérôme MOREAUXCSO and Co-Founder
Co-Founder of Diag2Tec, Jérôme is Associate Professor Hematology at Montpellier 1 University since 2014. He’s Group Leader of « Diagnosis and minimal residual disease of Mulitple Myeloma (MM) patients » into the laboratory « Monitoring Innovative Therapies » at the Montpellier University Hospital (CHU).
He has an worldwide recognition and strong expertise in MM pathologie

Diag2Tec Scientific Advisor Board

  • Jérôme Moreaux, PhD, Co-Founder, Associate Professor Hematology at Montpellier 1 University. Group Leader of « Diagnosis and minimal residual disease of Mulitple Myeloma (MM) patients » into the laboratory « Monitoring Innovative Therapies » at the Montpellier University Hospital (CHU).
  • Jean Luc Veyrune, PhD, Co-Founder, Engineer biologist within the unity of Cellular and Gene Therapy of Montpellier University Hospital and a member of INSERM-UM1 U1040 team. In charge for quality controls Therapy Unit Cell and Gene Montpellier (CHU)
  • Alboukadel Kassambara, PhD, Co-Founder, Postdoctoral position in Bioinformatic and research on Myeloma Biology into the laboratory « Monitoring Innovative Therapies » at the Montpellier University Hospital (CHU). Development of statistical tools for genomic data analysis
  • Philippe Pasero, PhD, Deputy Director of the Institute of Human Genetics (IGH Montpellier), Group leader of « Maintenance of Genome Integrity during DNA Replication » Department.
  • Guillaume Cartron, MD, PhD, Professeur of University (CHU Montpellier), Head of Hematology Department (UMR-CNRS 5235)
  • International experts recruitment – On going

They support Diag2Tec

  • Diag2Tec is supported by BPIFrance, the French SME funding organization and has been Nominated for « Creating innovative company » prize Ilab-2015.
  • Diag2Tec is supported and accompagned by the BIC (Business Innovation Center) of Montpellier Metropole and by The LRI (Languedoc Roussillon Incubator).
  • Diag2Tec is supported by TTO AxLR (chemogram maturation phase).
  • DIAG2TEC supported by CREALIA to improve the treatment of hematological cancers. Créalia allow them to strengthen their capital and accelerating the development of the company and especially R&D.
  • Diag2Tec is in demand (on going) to have a grant a Research Tax Relief (« Agrément Crédit Impôt Recherche ») by the French Ministry of Research and Technology.
  • Diag2Tec is in the process of applying for young innovative company « JEI, Jeune Entreprise Innovante » by the French Ministry of Research and Technology.